The AMWC has evolved over the years to keep up with the latest trends in aesthetic and anti-aging medicine while maintaining the highest standards.
This is the first time Singfiller® showed at the AMWC conference and continue the boom at IMCAS & Dubai Derma; Singfiller® had impressed the dermatologist with highest quality injection products.
During April 04th -06th, Singfiller® met with more than 50 customers from 20 different countries.
Our two new products interested the dermatologist and aesthetic physician during the conference.
Singderm® which is mono phase cross-linked hyaluronate acid gel implant. Smooth-consistency helps achieve a natural and harmonious look.
Hyaclean ® hyaluronic acid extract which used BD’s Uniject vaccine packaging to ensure the purity of each drop. Boosts the skin’s natural hyaluronic acid level in as little as 7 days.
With the progress Singfiller® made in AMWC 2019, we will ensures the continuous production of high-level injection products and satisfied our customer better.
-
singclean | 2019-04-15
Headlining FIGO 2025: A Can’t-Miss Keynote by Prof. Osama Shawki, Presented by Singclean & KSMSingclean, in partnership with Kayan Al-Seha Medical (KSM), will debut at FIGO 2025 in Cape Town with a keynote lecture by renowned gynecologist Professor Osama Shawki. His session will spotlight innovations in hysteroscopy and adhesion prevention, showcasing Singclean’s commitment to advancing women’s healthcare worldwide. -
singclean | 2019-04-15
Singclean Draws Major Attention at ESCRS 2025 with Advanced Viscoelastic Solution for Ophthalmic SurgeryCOPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world. -
singclean | 2019-04-15
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
